Number of manic episodes is associated with elevated DNA oxidation in bipolar i disorder

International Journal of Neuropsychopharmacology

Volumn 16, Issue 7, 2013, Pages 1505-1512

  Soeiro De Souza, Márcio Gerhardt ^a   Andreazza, Ana C ^b,c,d   Carvalho, Andre F ^e   Machado Vieira, Rodrigo ^a   Young, L Trevor ^b,c,d   Moreno, Ricardo Alberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF TORONTO   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^e FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

5 hydroxymethylcystosine; 5 methylcytosine; 8 hydroxy 2 deoxyguanosine; Key words Bipolar disorder; oxidative stress

Indexed keywords

5 METHYLCYTOSINE; DNA; GUANOSINE;

ADULT; ARTICLE; BIPOLAR I DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMETHYLATION; DEPRESSION; DNA METHYLATION; FEMALE; GENETIC ASSOCIATION; HUMAN; MALE; MANIA; MENTAL PATIENT; OXIDATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BIPOLAR DISORDER; CYTOSINE; DEOXYGUANOSINE; DNA; DNA METHYLATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; OXIDATION-REDUCTION; OXIDATIVE STRESS; YOUNG ADULT;

EID: 84880515619     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145713000047     Document Type: Article

References (68)

1. Abdolmaleky HM, Cheng K-H, Faraone SV, Wilcox M, Glatt SJ, Gao F, Smith CL, Shafa R, Aeali B, Carnevale J, Pan H, Papageorgis P, Ponte JF, Sivaraman V, Tsuang MT, Thiagalingam S (2006) Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 15:3132-3145.
2. Altieri F, Grillo C, Maceroni M, Chichiarelli S (2008) DNA damage and repair : From molecular mechanisms to health implications. Antioxid Redox Signal 10:891-937.
3. Andreazza AC, Frey BN, Erdtmann B, Salvador M, Rombaldi F, Santin A, Gonçalves CA, Kapczinski F (2007) DNA damage in bipolar disorder. Psychiatry Res 153:27-32.
4. Andreazza AC, Kauer-Sant'Anna M, Frey BN, Bond DJ, Kapczinski F, Young LT, Yatham LN (2008) Oxidative stress markers in bipolar disorder : A meta-analysis. J Affect Disord 111:135-144.
5. Berk M (2009) Neuroprogression : P athways to progressive brain changes in bipolar disorder. Int J Neuropsychopharmacol 12:441-445.
6. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yu? cel M, Gama CS, Dodd S, Dean B, Magalha?es PVS, Amminger P, McGorry P, Malhi GS (2011) Pathways underlying neuroprogression in bipolar disorder : Focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35:804-817.
7. Bora E, Yu? cel M, Pantelis C (2010) Neurocognitive markers of psychosis in bipolar disorder : A meta-analytic study. J Affect Disord 127:1-9.
8. Branco MR, Ficz G, Reik W (2012) Uncovering the role of 5- hydroxymethylcytosine in the epigenome. Nat Rev Genet 13:7-13.
9. Bromberg A, Bersudsky Y, Levine J, Agam G (2009) Global leukocyte DNA methylation is not altered in euthymic bipolar patients. J Affect Disord 118:234-239.
10. Buttner N, Bhattacharyya S, Walsh J, Benes FM (2007) DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia. Schizophr Res 93:33-41.
11. Campos RN, Costa LF, Bio DS, de Souza MGS, Garcia CRL, Deme'trio FN, Moreno DH, Moreno RA (2010) LICAVAL: Combination therapy in acute and maintenance treatment of bipolar disorder. Trials 11:72.
12. Cavanagh JTO, Van Beck M, Muir W, Blackwood DHR (2002) Case-control study of neurocognitive function in euthymic patients with bipolar disorder : An association with mania. Br J Psychiatry 180:320-326.
13. Chen Q, Fischer A, Reagan JD, Yan LJ, Ames BN (1995) Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci USA 92:4337-4341.
14. Choi JY, Kim HS, Kang HK, Lee DW, Choi EM, Chung MH (1999) Thermolabile 8-hydroxyguanine DNA glycosylase with low activity in senescence-accelerated mice due to a singlebase mutation. Free Radic Biol Med 27:848-854.
15. Clark L, Iversen SD, Goodwin GM (2002) Sustained attention deficit in bipolar disorder. Br J Psychiatry 180:313-319.
16. Coryell W, Leon AC, Turvey C, Akiskal HS, Mueller T, Endicott J (2001) The significance of psychotic features in manic episodes: A report from the NIMH collaborative study. J Affect Disord 67:79-88.
17. Dempster EL, Pidsley R, Schalkwyk LC, Owens S, Georgiades A, Kane F, Kalidindi S, Picchioni M, Kravariti E, Toulopoulou T, Murray RM, Mill J (2011) Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet 20:4786-4796.
18. DSM-IV PATFO (2000) Diagnostic and statistical manual of mental disorders : DSM-IV-TR. Washington, DC: American Psychiatric Publishing, Inc.
19. El-Badri SM, Ashton CH, Moore PB, Marsh VR, Ferrier IN (2001) Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder. Bipolar Disord 3 :79-87.
20. Evans DL et al. (2005) Mood disorders in the medically ill : scientific review and recommendations. Biol Psychiatry 58:175-189.
21. Everson-Rose SA, House JS, Mero RP (2004) Depressive symptoms and mortality risk in a national sample: Confounding effects of health status. Psychosom Med 66:823-830.
22. Ferrier IN, Thompson JM (2002) Cognitive impairment in bipolar affective disorder : Implications for the bipolar diathesis. Br J Psychiatry 180:293-295.
23. First MB, Spitzer RL, Williams JB (1996) Structured clinical interview for DSM-IV axis I disorders SCID-I. Washington, DC: American Psychiatric Press.
24. Forlenza MJ, Miller GE (2006) Increased serum levels of 8- hydroxy-2k-deoxyguanosine in clinical depression. Psychosom Med 68:1-7.
25. Gump BB, Matthews KA, Eberly LE, Chang Y-F, MRFIT Research Group (2005) Depressive symptoms and mortality in men: Results from the Multiple Risk Factor Intervention Trial. Stroke 36:98-102.
26. Gutteridge JM, Halliwell B (2010) Antioxidants : Molecules, medicines, and myths. Biochem Biophys Res Commun 393:561-564.
27. Guo JU, Su Y, Zhong C, Ming G-L, Song H (2011) Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145:423-434.
28. Gutteridge JM, Halliwell B (2000) Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 899:136-147.
29. Juster R-P, McEwen BS, Lupien SJ (2010) Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev 35:2-16.
30. Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant'Anna M, Grassi-Oliveira R, Post RM (2008) Allostatic load in bipolar disorder : Implications for pathophysiology and treatment. Neurosci Biobehav Rev 32:675-692.
31. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, Yatham LN (2009) Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol 12:447-458.
32. Klaunig JE, Kamendulis LM (2004) The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44:239-267.
33. Klungland A, Rosewell I, Hollenbach S, Larsen E, Daly G, Epe B, Seeberg E, Lindahl T, Barnes DE (1999) Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci USA 96:13300-13305.
34. Kohen R, Nyska A (2002) Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30:620-650.
35. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG (2011) Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res 711:193-201.
36. Kupfer DJ (2005) The increasing medical burden in bipolar disorder. J Am Med Assoc 293:2528-2530.
37. Kupper N, Gidron Y, Winter J, Denollet J (2009) Association between type D personality, depression, and oxidative stress in patients with chronic heart failure. Psychosom Med 71:973-980.
38. Kuratomi G, Iwamoto K, Bundo M, Kusumi I, Kato N, Iwata N, Ozaki N, Kato T (2008) Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Mol Psychiatry 13:429-441.
39. Laitinen J, Samarut J, Ho? ltta? E (1994) A nontoxic and versatile protein salting-out method for isolation of DNA. BioTechniques 17:316-322.
40. Lenaz G (2001) The mitochondrial production of reactive oxygen species : Mechanisms and implications in human pathology. IUBMB Life 52:159-164.
41. Lim S-O, Gu J-M, Kim MS, Kim H-S, Park YN, Park CK, Cho JW, Park YM, Jung G (2008) Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: Methylation of the E-cadherin promoter. Gastroenterology 135:2128-2140.
42. Lyoo IK, Sung YH, Dager SR, Friedman SD, Lee J-Y, Kim SJ, Kim N, Dunner DL, Renshaw PF (2006) Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord 8:65-74.
43. McEwen BS (2003) Interacting mediators of allostasis and allostatic load : Towards an understanding of resilience in aging. Metab Clin Exp 52:10-16.
44. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2009) Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuro Endocrinol Lett 30:715-722.
45. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389.
46. Mustak MS, Hegde ML, Dinesh A, Britton GB, Berrocal R, Subba Rao K, Shamasundar NM, Rao KSJ, Sathyanarayana Rao TS (2010) Evidence of altered DNA integrity in the brain regions of suicidal victims of Bipolar Depression. Indian J Psychiatry 52:220-228.
47. Nohesara S, Ghadirivasfi M, Mostafavi S, Eskandari M-R, Ahmadkhaniha H, Thiagalingam S, Abdolmaleky HM (2011) DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J Psychiatr Res 45:1432-1438.
48. Penninx BW, Guralnik JM, Pahor M, Ferrucci L, Cerhan JR, Wallace RB, Havlik RJ (1998) Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 90:1888-1893.
49. Plume JM, Beach SRH, Brody GH, Philibert RA (2012) A cross-platform genome-wide comparison of the relationship of promoter DNAmethylation to gene expression. Front Genet 3 :12.
50. Radak Z, Boldogh I (2010) 8-Oxo-7,8-dihydroguanine: links to gene expression, aging, and defense against oxidative stress. Free Radic Biol Med 49:587-596.
51. Robinson LJ, Ferrier IN (2006) Evolution of cognitive impairment in bipolar disorder : A systematic review of cross-sectional evidence. Bipolar Disord 8:103-116.
52. Rosa A, Picchioni MM, Kalidindi S, Loat CS, Knight J, Toulopoulou T, Vonk R, van der Schot AC, Nolen W, Kahn RS, McGuffin P, Murray RM, Craig IW (2008) Differential methylation of the X-chromosome is a possible source of discordance for bipolar disorder female monozygotic twins. Am J Med Genet B Neuropsychiatr Genet 147B:459-462.
53. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The mini-international neuropsychiatric interview (M.I.N.I.) : The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Suppl. 20) :22-33 ; quiz34-quiz57.
54. Shen J, Deininger P, Hunt JD, Zhao H (2007) 8-Hydroxy-2kdeoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. Cancer 109:574-580.
55. Shen S, Cooley DM, Glickman LT, Glickman N, Waters DJ (2001) Reduction in DNA damage in brain and peripheral blood lymphocytes of elderly dogs after treatment with dehydroepiandrosterone (DHEA). Mutat Res 480-481:153-162.
56. Spassky A, Angelov D (1997) Influence of the local helical conformation on the guanine modifications generated from one-electron DNA oxidation. Biochemistry 36:6571-6576.
57. Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, Shear P, Adler CM (2002) Ventricular and periventricular structural volumes in first- vs. multiple-episode bipolar disorder. Am J Psychiatry 159:1841-1847.
58. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD (1999) Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry 156:1264-1266.
59. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD (2000) Mania: differential effects of previous depressive and manic episodes on response to treatment. Acta Psychiatr Scand 101:444-451.
60. Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J, Dilsaver SC, Davis JM (1997) Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 54:37-42.
61. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930-935.
62. Tohen M, Waternaux CM, Tsuang MT (1990) Outcome in mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 47:1106-1111.
63. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J (2004) Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266:37-56.
64. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1-40.
65. Wachsman JT (1997) DNA methylation and the association between genetic and epigenetic changes: Relation to carcinogenesis. Mutat Res 375:1-8.
66. Wei Y-C, Zhou F-L, He D-L, Bai J-R, Ding H, Wang X-Y, Nan K-J (2009) Oxidative stress in depressive patients with gastric adenocarcinoma. Int J Neuropsychopharmacol 12:1089-1096.
67. Wood ML, Dizdaroglu M, Gajewski E, Essigmann JM (1990) Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome. Biochemistry 29:7024-7032.
68. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 133:429-435.